Logo

EU Research Groups Form Epigenome Consortium

Dec 31, 1999
Premium

B

ERLIN--Epigenomics, a biotech company here, has teamed up with researchers from several European research centers including the Sanger Center, the Max Planck Institute, the Centre National de Genotypage, the Technical University of Berlin, Medeea, and the German Cancer Research Institute to establish the Human Epigenome Consortium.

The company said the consortium will develop integrated technologies that provide an individual’s epigenotype or digital phenotype first by conducting genome-scale mapping of epigenetic parameters such as DNA-methylation; second, by identifying and analyzing epigenetic loci; and third, by comparing epigenetic information from different organisms.

Filed under

Informatics
Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.